Will any Zoom NEO (Yuan, Chang, Bawa, or Sankarlingam) make an open-market discretionary purchase of $100K or more by April 2027?

Strong empirical anchor: zero open-market discretionary buys across 4 NEOs over 4 observed months (Jan 9 - Apr 17, 2026), consistent with longstanding ZM pattern of plan-driven selling and zero conviction-buying. Yuan's multi-year history (FY20-FY26) shows no major open-market discretionary buys at depressed prices ($60-90 range), so the absence is a structural pattern not a recent anomaly. Coordinated June 2025 plan adoption (16-day window across Yuan/Chang/Bawa) signals institutional/routine governance behavior, not individualistic conviction-driven buying culture. Yuan's 22.5M Class B shares (31% voting, ~$1B+ paper value) make a $100K buy economically de minimis — symbolic value low relative to optical/regulatory friction. Corporate buyback (~$1B/year) is the actual signaling vehicle management uses; personal buys are redundant from their perspective. Plan re-adoption is path of least resistance post-expiration. Counter-factors: plan expirations (Yuan ~Nov 2026, Chang/Bawa ~Oct 2026) create a natural decision window covering ~5-6 months of resolution period; depressed valuation (14.5x forward P/E, 7.4% FCF yield) is textbook signaling environment; 4 independent NEOs provide multiple shots. Per-NEO annual probability estimate: Yuan ~5% (founder bias toward signaling but offset by existing concentration), Chang ~3%, Bawa ~3%, Sankarlingam ~2%. Combined P(any) = 1 - (0.95)(0.97)(0.97)(0.98) ≈ 0.12. Bayesian update from zero-in-4-months observation: if true annual rate were 25%, P(zero in 4 months across 4 NEOs) ≈ 35%; if 10%, ≈ 71%; observed zero is more consistent with rate <15%. Aggregate prior of 0.15 from committee is reasonable; I land slightly lower given the multi-year Yuan pattern and coordinated routine-plan culture which together suggest the underlying behavioral propensity is below the cross-sectional CEO buy base rate.

Anchoring on the committee's aggregate of 0.15 (96% model agreement) and reasoning from the established analysis facts. The base rate is the dominant factor: zero open-market discretionary buys across all four NEOs over the four-month Form 4 corpus, and the dossier flags this as a longstanding multi-year pattern (Yuan 2020-2025 history is plan-driven sells with no major open-market buys disclosed). Linear extrapolation from a 4-month zero-observation window to a 12-month window already implies a low frequency. Three structural factors push the probability further down: (1) Yuan's economic alignment via 22.5M Class B shares + 31% voting control + 561,588 RSU April 2026 grant is already maximal — incremental $100K+ buys are economically de minimis and create optical/scrutiny risk that may not justify the signaling value; (2) corporate buyback at ~$1B/year is the institutional 'vote of confidence' vehicle, making personal NEO buys structurally redundant from management's framework; (3) the path of least resistance post-plan-expiration is plan re-adoption for continued selling cadence, which is consistent with the coordinated 16-day window adoption pattern across Yuan/Chang/Bawa in June 2025 (signals routine, not individualistic conviction). Pushing up: the Nov 2026 / Oct 2026 plan expirations create a ~5-6 month post-expiration window during which discretionary buying is mechanically possible, and the textbook 'vote of confidence' opportunity exists at 14.5x forward non-GAAP P/E with reverse-DCF implying 1-3% perpetual growth against committee-assessed +4.4% accelerating delivery. However, the committee explicitly noted 'no public commentary signaling buy intent in any earnings call or proxy disclosure,' which is the strongest forward-looking negative. Disjunctive structure (any of 4 NEOs, $100K threshold which is low relative to NEO compensation) provides some lift from a pure individual base rate. Net: ~13% — slightly below committee aggregate, reflecting heavier weight on the longstanding behavioral pattern and the economic redundancy of a Yuan personal buy given his existing alignment.

Base rate is the dominant input. Zero open-market discretionary buys >=$100K occurred across all four NEOs over the four-month observed Form 4 corpus (Jan 9 - Apr 17, 2026), and the dossier indicates no such buys appear in the multi-year prior pattern either — Yuan and team have been exclusively plan-driven sellers for years. A naive base rate of 'zero buys observed in 4 months' linearly extrapolated to 12 months still implies a low (but not negligible) per-NEO probability for a single isolated buy event. With four eligible NEOs (Yuan, Chang, Bawa, Sankarlingam), the union probability lifts somewhat from any single-person base rate, but the correlated coordination (June 2025 16-day plan adoption cluster) suggests their behavior is jointly governed by a shared corporate playbook — they tend to act similarly, dampening independence assumptions and the union lift. The strongest YES paths are: (1) Yuan personally buys post-Nov 2026 plan expiration as a 'vote of confidence' at depressed valuation, (2) a stock dip below $70-75 triggers an opportunistic NEO buy. Both are plausible but historically rare — Yuan did not buy at any FY25-FY26 cycle low (~$60-90 range) per the dossier, and other CEOs cited (Narayen, Benioff, Nadella) are different reference classes. Counter-arguments dominate: the corporate buyback (~$1B/year) functions as the institutional vote of confidence, making personal buys redundant signaling; Yuan already holds 22.5M Class B + 31% voting control and is awarded 561,588 RSUs vesting through 2030 — his economic alignment is maximal without further buying; tax/concentration considerations make adding to concentrated personal positions unattractive; plan re-adoption is the documented path of least resistance. Multi-year baseline absence of buys is the strongest single anchor — when an executive has not bought in 5+ years across multiple price regimes, the conditional probability of a sudden break in pattern within any single 12-month window is empirically very low (~5-10% range for the cohort). I weight this slightly above pure linear extrapolation to account for: the genuine plan expiration decision point in months 6-12 of the window, the four-NEO union, and the modest possibility of a stock-dip-triggered signaling buy. Settling at 0.11 — meaningfully above 0 to reflect the four-NEO union and the salient plan expiration catalyst, but well below 0.20 to reflect the strong base rate, the redundancy of personal signaling given corporate buyback, and the absence of any public commentary indicating buy intent.

Base rate for NEO open-market discretionary buys is empirically very low at large-cap tech companies, and Zoom's observed pattern is 100% plan-driven sells with zero discretionary buys over the 4-month Form 4 corpus. The four-actor pool (Yuan, Chang, Bawa, Sankarlingam) provides meaningful upward pressure — any one of four actors can trigger YES — but structural factors dominate against. Post-expiration (Oct–Nov 2026), the compliance-optimal path is new 10b5-1 plan adoption, not discretionary buying: legal teams strongly favor ongoing 10b5-1 plans for liquidity management, and the coordinated June 2025 plan cluster across NEOs signals institutional compliance culture rather than individualistic conviction-driven behavior. Yuan's economic case for a personal buy is weak: his alignment is already maximal (31% voting control, 22.5M Class B shares, fresh April 2026 RSU grant), the $100K+ threshold is economically de minimis relative to his $1B+ paper value, and the corporate buyback (~$1B/year) already serves as the institutional signal vehicle management has chosen. The highest-probability YES window is Q4 FY27 (Nov 2026–Jan 2027), covering only ~5-6 months of the 12-month resolution window — which materially reduces expected frequency even if per-month probability picks up post-expiration. No public commentary in earnings calls or DEF 14A signals imminent buy intent. Landing at 0.12, slightly below the committee aggregate of 0.15, reflecting heavier weighting on plan re-adoption path and the sub-half-year post-expiration window.

The dominant empirical anchor is zero open-market discretionary purchases over the 4-month Jan–Apr 2026 Form 4 corpus across all four NEOs, including founder-CEO Yuan who has maximum information advantage and 31% voting control. The coordinated June 2025 plan adoption (16-day cluster across Yuan, Chang, Bawa) signals an institutionalized, routine selling cadence culture — not individualistic conviction-driven behavior. Three structural factors push strongly against YES: (1) the corporate ~$1B/year buyback program functions as the institutional 'vote of confidence' substitute, reducing the signaling pressure on NEOs to act personally; (2) post-plan-expiration (Oct/Nov 2026), the path of least resistance is new 10b5-1 plan adoption rather than breaking the buying pattern; and (3) Yuan's Class B paper value exceeds $1B, making a $100K discretionary buy economically trivial and exposing him to insider trading scrutiny optics without commensurate economic benefit. Offsetting factors: four NEOs creates a wider event universe than single-individual markets; plan expirations in Oct/Nov 2026 create a natural inflection where active selling cadence pauses and buying is structurally possible; stock at ~$84 / 14x forward non-GAAP P/E with committee-assessed positive growth re-acceleration is a textbook opportunistic entry backdrop; and Yuan's April 2026 RSU grant (561K shares to 2030) signals multi-year conviction consistent with a possible personal buy. However, no earnings call or proxy commentary has signaled buying intent. Industry base rate for tech NEO open-market buys runs ~10-15% per company per year, but ZM's specific institutional culture, zero historical baseline, and corporate buyback substitute argue for a material downward adjustment. I estimate combined YES probability across 4 NEOs at ~12%, slightly below the current aggregate of 0.15, primarily due to weight placed on the corporate buyback as the deliberate signaling vehicle choice and the high likelihood of plan re-adoption rather than discretionary activity post-expiration.

The zero-buys-in-4-months empirical record is the single most decisive input. Eric Yuan has maximum information advantage, 31% voting control, and ~22.5M Class B shares — the strongest possible conviction alignment — yet he has not made a single discretionary open-market purchase at ~$84/share (14.5x forward non-GAAP P/E, 7.4% FCF yield), a valuation the committee characterizes as pricing only 1-3% perpetual growth. This revealed preference is powerful: the stock is cheap by internal metrics, Yuan knows it better than anyone, and he still is not buying personally. The most likely explanation is that (a) the $1B/year corporate buyback is the chosen institutional signaling vehicle, making personal buys redundant, and (b) tax/concentration considerations make adding to an already-massive position economically irrational for personal portfolio management. The plan expiration window (Oct-Nov 2026) does create a decision point that modestly increases YES probability — but the path of least resistance post-expiration is re-adopting a new 10b5-1 plan to continue the established selling cadence. The coordinated June 2025 cluster adoption (Yuan, Chang, Bawa all within a 16-day window) is consistent with routine annual plan renewal, not conviction-driven buy signals. The four-NEO structure provides modest diversification — any one of four can trigger YES — but all four have zero discretionary buys in the corpus. Sankarlingam's plan details are less explicit, but he too shows zero buys. I weight YES probability at 0.13: higher than a naive base rate (~0.08 for any single NEO) due to the four-NEO multiplier and plan-expiration window, but below the ensemble aggregate of 0.15 because I weight the corporate-buyback-displacement effect and revealed-preference evidence more heavily than the optionality of plan expirations triggering a behavioral pivot.

Zero discretionary buys in 4-month Form 4 corpus despite $84 stock price and Yuan's 31% voting control establishes strong base rate against. All NEO selling is 10b5-1 plan-driven; plans expire Oct-Nov 2026, creating decision point but historical pattern favors plan re-adoption over discretionary buy. Corporate buyback (~$1B/year) provides institutional signaling vehicle, potentially rendering personal NEO buys redundant. Tax/concentration considerations weigh against stake accumulation. Post-expiration window (Nov 2026-Apr 2027) covers 5-6 months; any buy would signal shift from 'silence' pattern. Probability slightly above zero base rate due to stock valuation (14x forward non-GAAP P/E) creating textbook confidence opportunity, but organizational routine and zero historical precedent dominate.

Strong base-rate effect dominates: zero open-market discretionary purchases over Jan-Apr 2026 (4-month Form 4 corpus). All NEO selling is 10b5-1 plan-driven. Yuan has 31% voting control + $1B+ Class B holdings, making incremental $100K+ buy symbolically valuable but economically de minimis. Plan expirations (Yuan Nov 2026, Chang/Bawa Oct 2026) create a natural decision point mid-window, but historical pattern and coordinated June 2025 plan adoption cycle suggest path of least resistance is plan re-adoption, not discretionary buying. Corporate buyback (~$1B/year) may serve as management's preferred signal vehicle. No public commentary signals buy intent. Committee flagged this as unresolved — genuine debate between whether expirations trigger buys or re-adoptions. 0/4 months extrapolates to ~8-10% annualized frequency; 12-month window suggests <15% tail probability.

Base rate of zero discretionary buys in 4-month Form 4 corpus (Jan-Apr 2026) extrapolates to ~0.5 expected buys over 12-month window, yielding ~4% baseline. Yuan's multi-decade pattern of plan-driven selling (not opportunistic buys) despite prior multi-year lows reinforces historical bias against discretionary buying. Post-plan-expiration path of least resistance is routine plan re-adoption rather than new buying signal. However, plan expirations (Yuan Nov 2026, Chang/Bawa Oct 2026) create a natural decision point in months 7-12 of resolution window where NEOs must choose between plan re-adoption, discretionary buying, or discretionary selling. Yuan's April 2026 RSU grant extends alignment to 2030. Stock at $84 (14.5x forward non-GAAP) is depressed relative to analyst consensus but offers limited signaling value given Yuan's 31% voting control ($1B+ paper value). Committee flagged plan expiration behavior as unresolved monitoring catalyst. Probability weighted toward post-expiration window density (6 months vs. 6 months pre-expiration) with modest upward adjustment for decision-point catalyst, offset by entrenched historical pattern against buying.